ARCHIVES

Revlimid Shows 91 Percent Response in Non-Hodgkin’s

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Drug for Advanced Kidney Cancer

May 25, 2007

NIH Backs Down Agrees Nurses May Be Hired Into Commissioned Corps

June 13, 1986

Complete List of Recommendations by Centers Committee

October 18, 1996

Lawrence Corey Named President Of Fred Hutchinson Cancer Research Center

August 6, 2010

FDA Adopts Final Diagnostics X-Ray Rule Amendment

September 9, 1977

FDA Lists Therapies being Tested For AIDS, Opportunistic Infections

January 24, 1992